Athira Pharma, Inc.
NASDAQ:ATHA
0.4 (USD) • At close August 27, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.97 | 0.969 | 1.048 | 0.479 | 2 | 0 | 0 |
| Gross Profit
| -0.97 | -0.969 | -1.048 | -0.479 | -2 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 69.712 | 92.821 | 61.464 | 42.794 | 13.286 | 3.793 | 3.589 |
| General & Administrative Expenses
| 26.093 | 33.304 | 32.552 | 21.228 | 6.709 | 1.656 | 1.42 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 26.093 | 33.304 | 32.552 | 21.228 | 6.709 | 1.656 | 1.42 |
| Other Expenses
| 0 | 0 | -1.048 | -0.479 | -2 | -0.754 | 0 |
| Operating Expenses
| 95.805 | 126.125 | 92.968 | 63.543 | 17.995 | 4.695 | 5.009 |
| Operating Income
| -100.902 | -127.094 | -104.016 | -64.022 | -19.995 | -5.449 | -5.009 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.962 | 9.422 | 8.377 | 9.169 | 0.04 | 0.288 | -0.088 |
| Income Before Tax
| -96.94 | -117.672 | -95.639 | -54.853 | -19.955 | -5.161 | -5.097 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | -0.459 | 0 |
| Net Income
| -96.94 | -117.672 | -95.639 | -54.853 | -19.955 | -5.161 | -5.097 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.52 | -3.09 | -2.53 | -1.49 | -0.61 | -0.14 | -0.16 |
| EPS Diluted
| -2.52 | -3.09 | -2.53 | -1.49 | -0.61 | -0.14 | -0.16 |
| EBITDA
| -95.97 | -116.703 | -94.591 | -54.371 | -19.993 | -4.815 | -0.079 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |